{"id":"cd7","name":"CD7","symbol":"CD7","route":"/targets/cd7/","asOf":"2026-09-08","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1695","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173762","uniprot":"https://www.uniprot.org/uniprotkb/P09564/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P09564","open-targets":"https://platform.opentargets.org/target/ENSG00000173762","civic":"https://civicdb.org/genes/924/summary","oncokb":"https://www.oncokb.org/gene/CD7","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CD7","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=CD7","depmap":"https://depmap.org/portal/gene/CD7?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000173762-CD7","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/924","omim":"https://www.omim.org/entry/186820"}],"products":[],"trials":[{"id":"nct05885464","name":"A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)","nct":"NCT05885464","phase":"1/2","status":"active"}],"pathways":[],"companies":[],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}